Hangzhou Coco Healthcare Products financials at a glance
| Year | Year | 2021 | 2022 | 2020 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥1.19B | ¥1.19B | ¥1.64B | ¥0.00M | ¥0.00M |
| GM % | Gross Margin % |
|
17.97% | 12.11% | 27.70% | 0.00% | 0.00% |
| OM | Operating Margin |
|
2.86% | -3.47% | 18.92% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
¥0.14 | ¥-0.18 | ¥-0.18 | ¥0.00 | |
| Div. | Dividends |
|
¥0.07 | ¥0.07 | ¥0.00 | ¥0.07 | ¥0.00 |
| PR % | Payout Ratio % |
|
50.00% | -38.89% | 0 | -38.89% | 0 |
| Sha. | Shares |
|
271.86m | 271.86m | 0m | 271.86m | 271.86m |
| OCF | Operating Cash Flow |
|
¥50.53M | ¥-37.20M | ¥395.86M | ¥0.00M | ¥0.00M |
| FCF | Free Cash Flow |
|
¥-189.92M | ¥-153.60M | ¥175.15M | ¥0.00M | ¥0.00M |
| FCFS | Free Cash Flow Per Share |
|
¥-0.81 | ¥-0.57 | ¥0.86 | ¥0.00 | ¥0.00 |